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Ⅰ?Introduction
 Serine proteinase inhibitors ?serpin? consist 
of structurally related proteins participating 
in the regulation of complex physiological 
processes and contain over 500 members in 
the genomes of most metazoan, plants, and 
certain viruses?1,2?. In humans, more than 35 
serpin members are known to participate in 
extracellular and intracellular physiological 
processes. The primary function of serpin 
family members appears to be neutralizing 
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SUMMARY
Headpin, which is located at chromosome 18q21.3, belongs to serine proteinase inhibitor 
family ?serpin?. One of the functions of this gene family is believed to inhibit hemangiogenesis, 
invasion, and metastasis of tumors. In this study, 30 clinical tissue specimens of oral squamous 
cell carcinoma ?OSCC? and 9 OSCC-derived cell lines were examined for the down regulation 
of the gene expression. In addition, the restoration of headpin mRNA expression induced by 
5-Aza-2?-deoxycytidine ?5-AzaC? treatment, a DNA demethylating agent, was evaluated in 
OSCC-derived cell lines. RT-PCR revealed the down-regulation of headpin gene expression in 
17 ?56.7%? of 30 primary OSCC samples and in 5 ?55.6%?; SAS, HSC-3, OK92, HO-1-N-1 and 
SCC4, of 9 OSCC-derived cell lines. Among those 5 cell lines, 5-AzaC treatment induced the 
restoration of headpin gene expression in 4 ?80.0%? cell lines; SAS, HSC-3, OK92 and SCC4. 
These results suggested that the down-regulation of headpin expression contributes to the 
development of human OSCC and that DNA hypermethylation is one of the important mecha-
nisms inactivating the headpin gene in oral carcinogenesis.
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overexpressed serine proteinase activity 
and serpins play an important role in blood 
coagulation, inflammation, cell migration, 
fibrinolysis, complement activation, remodeling 
of extracellular matrix, hormone transport, 
hemangiogenesis, apoptosis, cancer growth, 
invas ion ,  and metastas is?1,2,3?.  A novel 
serpin named headpin was recently identified, 
cloned and mapped to chromosome 18q21.3
?4,5?. The cloning of hurpin/P113, which has a 
sequence identical to that of headpin, was also 
reported?6?. Serpin families tend to cluster at 
specific chromosomal locations. The ov-serpin 
family, including headpin, maspin, SCCA1, 
SCCA2, and PAI2, clusters at 18q21?7,8?and 
several reports, including our previous paper, 
indicated frequent loss of heterozygosity at the 
18q21-23 chromosomal region in head and neck 
carcinomas and other solid malignancies?9-12?. 
There have been only few reports validating the 
roles of headpin gene in many clinical samples 
and tumor cell lines, especially in OSCC.
 In the present study, in order to clarify the 
role of the headpin gene in OSCC, 30 clinical 
tissue specimens of OSCC and 9 OSCC-derived 
cell lines were examined for the status of the 
gene expression level. Moreover, the restoration 
of headpin mRNA expression by 5-AzaC 
treatment was evaluated in OSCC-derived cell 
lines.
Ⅱ?Materials and Methods
Clinical tissue samples.
 Thirty pairs of primary OSCC tissue 
samples and adjacent normal oral epithelia 
were obtained at the time of surgical resection 
from 1995 to 2001 at Chiba University Hospital. 
Informed consent was obtained from all 
patients and the patient?s families. One part of 
each tissue sample was frozen and stored at 
?80? for RNA extraction, and the remaining 
tissues were examined microscopically to 
confirm the diagnosis and to evaluate tissue 
morphology. The histopathological classification 
was performed according to the International 
Histological Classification of Tumors and the 
clinical staging was determined by the UICC 
TNM staging system. The patients, from whom 
the tissue specimens were obtained, were well 
informed and consented to offer their tissues for 
this study.
Cell lines
 The following OSCC-derived cell lines were 
analyzed: SAS, HSC-2, HSC-3, HSC-4, Ca9-22, 
HO-1-u-1, HO-1-N-1, SCC4 ?Human Science 
Research Resource Bank, Osaka, Japan? and 
OK92 ?established in our department from a 
carcinoma of the tongue?. All cell lines were 
cultured in RPMI-1640 medium with 10% fetal 
bovine serum and 50 units/ml penicillin and 
streptomycin in an atmosphere of 5% CO2 at 
37?.
RNA extraction
 Total RNA was extracted from cell lines 
and tissue samples using Trizol ?Invitrogen 
Life Technologies, CA USA? according to 
the manufacture?s instructions. Extracted 
RNAs were subjected to Affimetrix GeneChip 
hybridization or cDNA synthesis.
Affimetrix GeneChip hybridization
 Double-stranded cDNA was synthesized 
from 20 µg of total RNA using the Superscript 
Choice system ?Invitrogen?. After phenol/
chloroform extraction and ethanol precipitation, 
a biotin-labeled in vitro transcription reaction 
was carried out using the cDNA template 
?Enzo Bioarray, Farmingdale, NY, USA?. Seven 
microgram of cRNA was fragmented according 
to Affimetrix protocols and added to the 
recommended hybridization mixture. Expression 
profiles were created using the Human Genome 
U 133 Plus 2.0 arrays containing 54,675 probe 
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sets ?Affimetrix, Santa Clara, CA, USA?. Arrays 
were stained with phycoerythrin-streptavidin 
antibody followed by a second staining with 
phycoerythrin-streptavidin. Arrays stained a 
second time were scanned using the Affimetrix 
GeneChip Operating Software 1.1 ?Affimetrix? 
and then genes of the serpin superfamily were 
classified by GeneSpring 6.1 ?Silicon Genetics, 
Redwood City, CA, USA?.
Evaluation of suppressed expression of headpin 
gene by semiquantitative RT-PCR method.
 PCR reactions were performed in a 9700 
Perkin-Elmer Thermal Cycler at 94? for 1 
min, with 35cycles of 94 ? for 1 min, 55 ? for 
90s, and 72? for 90s, followed by an extension 
step at 72? for 10 min. After amplification, an 
aliquot of the PCR product was separated on a 
3% TAE-agarose gel and staind with ethidium 
bromide. All subsequent assays were carried 
out using parameters that yielded amplification 
of both the headpin and GAPDH genes within 
a linear range. cDNA was amplified by PCR 
using primers specific for cDNA of the headpin 
gene ?Table 1?. And the GAPDH gene was also 
amplified using specific primers as an internal 
control ?Table 1?13?. The density of the 
ethidium bromide-stained bands was analyzed 
using the NIH Image software. The results were 
normalized as a ratio of each specific mRNA 
signal to the GAPDH gene signal within the 
same RNA sample. cDNA obtained from normal 
oral epithelium was used as a positive control. 
Reproducibility was confirmed by processing all 
samples at least twice.
Evaluation of headpin mRNA expression in 
OSCC-derived cell lines by 5-Aza-2?-deoxycytidine 
treatment.
 We examined the promoter region of 
headpin gene for CpG island. However, no CpG 
island was found in the region of 2100 residues 
upstream from exon 1. Therefore we?re not able 
to perform methylation specific RT-PCR method.
 To assess restoration of headpin expression, 
the cells were treated with 2µM of the 5-AzaC 
as described previously?14?. On the day 5, 
the cells were washed with PBS and grown 
for another 10 days without 5-AzaC. After 
total RNA isolation from these samples, RT-
PCR analysis was performed with the same 
procedures as described above.
Ⅲ?Results
Microarray analysis.
 To detect down-regulated genes in OSCC, 
microarray analysis was performed using 4 
OSCC samples. The data showed that there 
were 13 genes which were down-regulated in 
all of 4 samples. Table 2 summarizes the list 
of those genes ?Table 2?. Among them, we 
focused on headpin gene and we analyzed the 
association of this gene in OSCC.
The status of headpin gene in primary OSCC 
tissue specimens and OSCC-derived cell lines.
 Semi-quantitative RT-PCR of headpin gene 
was performed. We examined 30 cases of oral 
SCC and 9 cell lines derived from oral SCC. 
mRNA expression of headpin was not observed 
in 4 of 9 cell lines; SAS, HSC-3, HO-1-N-1, SCC4, 
and slight expression was detected in OK92 
cell line ?Fig. 1?. And 17 ?56.7%? of 30 cases 
Table 1?Sequences of specific primers used in RT-PCR analyses.
Gene Sense Anti-sense
Headpin 5?-GTCCAGGGCATATGGAAGAA-3?, 5?-GGGATGATTGCAGTGAACATT-3?,
GAPDH 5?-CATCTCTGCCCCCTCTCTGCTCA-3? 5?-GGATGACCTTGCCACAGCCT-3?
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showed much suppressed expression of headpin 
gene ?Fig. 2?. However, significant correlation 
between clinicopathological characteristics and 
headpin expression was not indicated ?Table 3?. 
Evaluation of headpin mRNA expression in 
OSCC-derived cell lines by 5-AzaC treatment.
 In order to determine whether methylation 
might inhibit headpin mRNA expression, 5 cell 
lines in which showed headpin expression was 
down-regulated; SAS, HSC-3, OK92, HO-1-N-1 
and SCC4, were exposed to demethylating 
Table 2?Down-regulated genes in OSCC samples detected by microarray analysis.
Clone name Definition Molecular function
HOR015F11 Headpin gene, serine proteinase inhibitor heamangiogenesis, invasion and metastasis
HOR033H04 clone RP11-395A13 Unknown 
HOR050F08 mRNA for adracalin ?ADRACALA gene? Mediating protein-protein interactions
HOR029G07 tubulin-folding cofactor C mRNA Tubulin-specific chaperone 
HOR046F07 Glucocorticoid receptor unknown
GS012G05 LIM domain binding 1, clone MGC:8702,mRNA Modulating trannscriptional activation
HOR031B04 DNA sequence from c lone 422G23 ,  on 
chromosome6q24
Unknown
HOR022A09 prolactin regulatory element binding, clone 
MGC: 3467, mRNA
Unknown
HOR006C11 mRNA for seryl-tRNA synthetase Cytosolic seryl-tRNA synthetase
HOR030H04 Similar to vesicle trafficking protein, Clone, 
MGC: 13261
Acting in the early stages of the secretory 
pathway
HOR026D08 Sequence 215 from patent WO017611 Unknown
HOR015C06 KIAA0428mRNA Unknown
HOR031B03 Sequence 1 from patent US 5869284 Unknown
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Fig. 1? mRNA expression of headpin gene in 
OSCC-derived cell lines analyzed by RT-
PCR.
?Headpin mRNA expression was not observed 
in 4 cell lines ?SAS, HSC-3, HO-1-N-1, SCC4? and 
slight expression was shown in OK92 cell line. 
Asterisks show cell lines in which headpin mRNA 
expression was down-regulated. 
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Fig. 2? Representative results of RT-PCR 
ana lys is  for  the down-regulated 
expression of headpin gene in clinical 
OSCC tissue specimens.
?mRNA expressions of headpin gene were 
significantly down-regulated in tumor samples 
compared with normal samples.
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agent 5-AzaC, which could restore mRNA 
expression suppressed by gene methylation. 
After treatment with 5-AzaC, the expression 
of headpin mRNA was restored in SAS, HSC-3, 
OK92 and SCC4 ?Fig. 3?. The data suggested 
that hyper-methylation was closely related with 
down-regulated expression of headpin gene in 
OSCC.
Ⅳ?Discussion
 cDNA microarray identified 13 genes with 
down regulated mRNA expression in OSCC, 
comparing with normal oral epithelium. Out 
of these genes, headpin gene was singled out 
as a candidate gene for a tumor suppressor 
gene associated with oral SCC, because of 
Table 3?Correlation between clinicopathological characteristics and down-regulation of headpin gene.
Clinicopathological factor
Total number 
of cases
Down-expression of Headpin;
number of cases ?%?*
P-value
Gender
 Male 17 9? 53.0?
0.721
 Female 13 8? 61.5?
Age
 <60 10 4? 40.0?
 60<, <70 11 7? 63.6? 0.471
 70< 9 6? 66.7?
Tumor size
 T1 4 2? 50.0?
 T2 13 8? 61.5?
0.624
 T3 2 2?100.0?
 T4 11 5? 45.5?
Stage
 I 4 2? 50.0?
 II 9 4? 44.4?
0.332
 III 4 2?100.0?
 IV 13 7? 53.8?
Histological differentiation
 Well 18 8? 44.4?
 Moderately 10 8? 80.0?
0.261
 Poorly 2 1? 50.0?
 Primary site
Tongue 11 6? 54.5?
 Oral floor 2 2?100.0?
 Buccal mucosa 3 3?100.0? 0.354
 Gingiva 14 9? 64.3?
?*; cases with down-regulation of headpin gene in tumor tissues compared with normal tissues.
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Fig. 3? RT-PCR analysis for the demethylation 
study of OSCC-derived cell lines. After 
treatment with 5-AzaC, restoration of 
headpin mRNA expression was found 
in the 4 cell lines; SAS, HSC-3, OK-92 
and SCC4, of 5 ones which showed 
down-regulation of the gene before the 
treatment. ?-?, before 5-AzaC treatment; 
?+?, after 5-AzaC treatment; GAPDH, 
internal marker.
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its molecular function; heamangiogenesis, 
invasion and metastasis ?Table 2?. The high 
frequency of down regulated expression of 
headpin gene in primary oral SCC specimens 
supported this hypothesis and suggested the 
important role of the gene in oncogenesis of 
oral SCC. However, no significant relationship 
between the down expression of the gene and 
the clinicopathological features was found in 
our results. Thus, further investigations should 
be necessary to clarify clinical roles of down-
expression of headpin gene.
 Headpin is a novel serine proteinase inhibitor 
and localized at chromosome 18q21.3, which is 
expressed in normal squamous epithelium of 
the oral mucosa, skin and cervix?4?. Inhibitory 
serpins are known to play an important role in 
tumor invasion, metastasis, tumor suppression 
and apoptos is?5-7?,  and their sequences 
have homology with the ovalbumin serpins 
?ov-serpins? which include the squamous 
cell carcinoma antigens ?SCCA1, SCCA2?, 
plasminogen activator inhibitor-2 ?PAI2? and 
maspin. In humans, the ov-serpins share 40% 
amino acid sequence identity, contain seven or 
eight exons, lack typical signal peptides and 
map to one of two chromosomal clusters. P16, 
p19 and ELNAH2 map to 6p25, whereas p15 
?maspin?, SCCA2, SCCA1, PAI2, PI10 and 
p18 map to within a 500kb interval of 18q21.3
?8?. Deletion and LOH at 18q21 are frequent in 
several types of tumors?9,10?. Moreover, our 
data suggest that hypermethylation of headpin 
is one of the crucial mechanisms inducing the 
down-regulation of headpin gene expression. 
These results indicate that the clustering of ov-
serpins at 18q21.3 and hypermethylation assay 
may have important diagnostic considerations 
when assessing tumor phenotypes. In this study, 
there was no relationship between the status 
of the gene expression and clinicopathological 
findings. Therefore, further study will be 
necessary to establish the diagnostic method of 
assessing tumor phenotypes.
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